• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与喹啉-硫代氨基脲共轭的取代哌嗪作为有效的α-葡萄糖苷酶抑制剂以靶向高血糖症。

Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent α-glucosidase inhibitors to target hyperglycemia.

作者信息

Ghasemi Mehran, Mahdavi Mohammad, Dehghan Maryam, Eftekharian Mohammadreza, Mojtabavi Somayeh, Faramarzi Mohammad Ali, Iraji Aida, Al-Harrasi Ahmed

机构信息

Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, P. O. Box 33, Nizwa, Oman.

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

出版信息

Sci Rep. 2025 Jan 13;15(1):1871. doi: 10.1038/s41598-024-83917-z.

DOI:10.1038/s41598-024-83917-z
PMID:39805968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11730591/
Abstract

Diabetes mellitus, particularly type 2 diabetes, is a growing global health challenge characterized by chronic hyperglycemia due to insulin resistance. One therapeutic approach to managing this condition is the inhibition of α-glucosidase, an enzyme involved in carbohydrate digestion, to reduce postprandial blood glucose levels. In this study, a series of thiosemicarbazide-linked quinoline-piperazine derivatives were synthesized and evaluated for their α-glucosidase inhibitory activity, to identify new agents for type 2 diabetes management. Structure-activity relationship (SAR) analysis revealed that the nature and position of substituents on the aryl ring significantly impacted the inhibitory potency. Among the synthesized derivatives, the 2,5-dimethoxy phenyl substitution (7j) exhibited the most potent activity with an IC value of 50.0 µM, demonstrating a 15-fold improvement compared to the standard drug acarbose. Kinetic studies identified compound 7j as a competitive inhibitor, with a K value of 32 µM. Molecular docking simulations demonstrated key interactions between compound 7j and the active site of α-glucosidase, while molecular dynamics simulations confirmed the stability of the enzyme-ligand complex, reflected in low RMSD and RMSF values.

摘要

糖尿病,尤其是2型糖尿病,是一项日益严峻的全球健康挑战,其特征是由于胰岛素抵抗导致慢性高血糖。控制这种疾病的一种治疗方法是抑制α-葡萄糖苷酶,该酶参与碳水化合物消化,以降低餐后血糖水平。在本研究中,合成了一系列硫代氨基脲连接的喹啉-哌嗪衍生物,并评估了它们的α-葡萄糖苷酶抑制活性,以确定用于管理2型糖尿病的新药物。构效关系(SAR)分析表明,芳环上取代基的性质和位置对抑制效力有显著影响。在合成的衍生物中,2,5-二甲氧基苯基取代物(7j)表现出最有效的活性,IC值为50.0 µM,与标准药物阿卡波糖相比有15倍的改善。动力学研究确定化合物7j为竞争性抑制剂,K值为32 µM。分子对接模拟表明化合物7j与α-葡萄糖苷酶活性位点之间存在关键相互作用,而分子动力学模拟证实了酶-配体复合物的稳定性,这体现在低RMSD值和RMSF值上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/078785ecfbf0/41598_2024_83917_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/ccb42be63dae/41598_2024_83917_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/603bc0106ff4/41598_2024_83917_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/b52f8ad4fbe3/41598_2024_83917_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/7aa30ecb6ec7/41598_2024_83917_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/d87cdd1be290/41598_2024_83917_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/58ab2f7878f7/41598_2024_83917_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/422e90c26ca8/41598_2024_83917_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/078785ecfbf0/41598_2024_83917_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/ccb42be63dae/41598_2024_83917_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/603bc0106ff4/41598_2024_83917_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/b52f8ad4fbe3/41598_2024_83917_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/7aa30ecb6ec7/41598_2024_83917_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/d87cdd1be290/41598_2024_83917_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/58ab2f7878f7/41598_2024_83917_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/422e90c26ca8/41598_2024_83917_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd74/11730591/078785ecfbf0/41598_2024_83917_Fig7_HTML.jpg

相似文献

1
Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent α-glucosidase inhibitors to target hyperglycemia.与喹啉-硫代氨基脲共轭的取代哌嗪作为有效的α-葡萄糖苷酶抑制剂以靶向高血糖症。
Sci Rep. 2025 Jan 13;15(1):1871. doi: 10.1038/s41598-024-83917-z.
2
Rational design of new quinoline-benzimidazole scaffold bearing piperazine acetamide derivatives as antidiabetic agents.新型含哌嗪乙酰胺衍生物的喹啉 - 苯并咪唑骨架作为抗糖尿病药物的合理设计。
Bioorg Chem. 2024 Dec;153:107908. doi: 10.1016/j.bioorg.2024.107908. Epub 2024 Oct 29.
3
Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study.探索查尔酮-磺酰基哌嗪杂化物作为抗糖尿病候选物:设计、合成、生物学评价及分子对接研究
Mol Divers. 2025 Feb;29(1):43-59. doi: 10.1007/s11030-024-10831-x. Epub 2024 May 22.
4
Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.吡喃并[3,2-c]喹啉衍生物作为新型α-葡萄糖苷酶抑制剂治疗2型糖尿病:合成、体外生物学评价及动力学研究
Med Chem. 2019;15(1):8-16. doi: 10.2174/1573406414666180528110104.
5
Novel thiosemicarbazide-based β-carboline derivatives as α-glucosidase inhibitors: Synthesis and biological evaluation.新型硫代卡巴肼基β-咔啉衍生物作为α-葡萄糖苷酶抑制剂的合成与生物评价。
Eur J Med Chem. 2024 Sep 5;275:116595. doi: 10.1016/j.ejmech.2024.116595. Epub 2024 Jun 12.
6
Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline-pyrazolopyrimidine hybrids and Quinoline-4-Arylamines.喹啉-吡唑并嘧啶杂合体和喹啉-4-芳胺的合成、抗糖尿病和抗结核评估。
ChemistryOpen. 2024 Sep;13(9):e202400014. doi: 10.1002/open.202400014. Epub 2024 Mar 20.
7
Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based α-glucosidase inhibitors.基于喹啉的α-葡萄糖苷酶抑制剂的合成、体外抑制活性、酶动力学和计算机模拟研究。
Sci Rep. 2024 Jan 4;14(1):501. doi: 10.1038/s41598-023-50711-2.
8
Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives.6-氯-2-甲氧基吖啶与三唑衍生物的合成、α-葡萄糖苷酶抑制活性及分子动力学模拟。
Sci Rep. 2024 Jul 28;14(1):17338. doi: 10.1038/s41598-024-68176-2.
9
Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.新型二氢吡喃并[3,2-c]喹啉衍生物的设计、合成及体外α-葡萄糖苷酶抑制活性研究作为潜在的抗糖尿病药物。
Bioorg Chem. 2018 Apr;77:280-286. doi: 10.1016/j.bioorg.2018.01.025. Epub 2018 Feb 3.
10
Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.将吖啶连接到硫代乙酰胺上作为治疗 2 型糖尿病的新型药物的设计、合成、对接研究、α-葡萄糖苷酶抑制作用和细胞毒性活性。
Bioorg Chem. 2018 Oct;80:288-295. doi: 10.1016/j.bioorg.2018.06.035. Epub 2018 Jun 30.

引用本文的文献

1
Anti-Leukemic Profiling of Oxazole-Linked Oxadiazole Derivatives: A Computational and Kinetic Approach.恶唑连接的恶二唑衍生物的抗白血病分析:一种计算和动力学方法。
Pharmaceuticals (Basel). 2025 Apr 25;18(5):625. doi: 10.3390/ph18050625.
2
Synthesis, Molecular Simulation, DFT, and Kinetic Study of Imidazotriazole-Based Thiazolidinone as Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase Enzymes.基于咪唑并三唑的噻唑烷酮作为乙酰胆碱酯酶和丁酰胆碱酯酶双重抑制剂的合成、分子模拟、密度泛函理论及动力学研究
Pharmaceuticals (Basel). 2025 Mar 15;18(3):415. doi: 10.3390/ph18030415.

本文引用的文献

1
Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives.6-氯-2-甲氧基吖啶与三唑衍生物的合成、α-葡萄糖苷酶抑制活性及分子动力学模拟。
Sci Rep. 2024 Jul 28;14(1):17338. doi: 10.1038/s41598-024-68176-2.
2
Morpholine, Piperazine, and Piperidine Derivatives as Antidiabetic Agents.吗啡啉、哌嗪和哌啶衍生物作为抗糖尿病药物。
Molecules. 2024 Jun 26;29(13):3043. doi: 10.3390/molecules29133043.
3
Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: In silico, in vitro, and in vivo evaluations.
不同取代基的含咪唑硫代喹啉衍生物的α-葡萄糖苷酶抑制和降血糖作用:计算机模拟、体外和体内评价
Bioorg Chem. 2024 Mar;144:107106. doi: 10.1016/j.bioorg.2024.107106. Epub 2024 Jan 8.
4
Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based α-glucosidase inhibitors.基于喹啉的α-葡萄糖苷酶抑制剂的合成、体外抑制活性、酶动力学和计算机模拟研究。
Sci Rep. 2024 Jan 4;14(1):501. doi: 10.1038/s41598-023-50711-2.
5
Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies.含不同 2-甲氧基苯氧基乙酰胺的芳基喹啉-4-甲酰腙作为有效的α-葡萄糖苷酶抑制剂;分子动力学、动力学和构效关系研究。
Sci Rep. 2024 Jan 3;14(1):388. doi: 10.1038/s41598-023-50395-8.
6
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments.糖尿病:分类、介质和并发症;寻找新有效治疗方法的潜在靶点的途径。
Biomed Pharmacother. 2023 Dec;168:115734. doi: 10.1016/j.biopha.2023.115734. Epub 2023 Oct 17.
7
Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors.3-甲酰基-6-异丙基色酮衍生的缩氨基硫脲的合成、生物评价及分子模拟作为α-葡萄糖苷酶抑制剂。
Bioorg Chem. 2023 Oct;139:106739. doi: 10.1016/j.bioorg.2023.106739. Epub 2023 Jul 17.
8
Synthesis, ADMT prediction, and and α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides.新型喹啉-喹唑啉酮-硫代乙酰胺的合成、ADMT预测及α-葡萄糖苷酶抑制活性评估
RSC Adv. 2023 Jun 26;13(28):19243-19256. doi: 10.1039/d3ra01790g. eCollection 2023 Jun 22.
9
Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.苯并咪唑-硫代喹啉衍生物的合成及构效关系研究作为α-葡萄糖苷酶抑制剂。
Sci Rep. 2023 Mar 16;13(1):4392. doi: 10.1038/s41598-023-31080-2.
10
Recent advances in functionalized quinoline scaffolds and hybrids-Exceptional pharmacophore in therapeutic medicine.功能化喹啉支架及杂化物的最新进展——治疗医学中的特殊药效基团
Front Chem. 2023 Jan 6;10:1074331. doi: 10.3389/fchem.2022.1074331. eCollection 2022.